SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
WEIGHT GAIN DURING ART
- Sort by:
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
13 of
13
|
WEIGHT GAIN AFTER SWITCHING DIFFERENT INTEGRASE STRAND TRANSFER INHIBITORS (INSTIS) (ABSTRACT
503)
Grace A McComsey
University Hospitals Cleveland Medical Center, Cleveland, OH, USA
WEIGHT GAIN AMONG PWH WHO SWITCH TO ART-CONTAINING INSTIS OR TAF (ABSTRACT
504)
Frank Palella
Northwestern University, Chicago, IL, USA
WEIGHT AND LIPID CHANGES IN PHASE 3 CABOTEGRAVIR AND RILPIVIRINE LONG-ACTING TRIALS (ABSTRACT
505)
Parul Patel
ViiV Healthcare, Research Triangle Park, NC, USA
ASSESSMENT OF OBESITY AND METABOLIC PROFILE BY INTEGRASE INHIBITOR USE IN REPRIEVE (ABSTRACT
506)
Janet Lo
Massachusetts General Hospital, Boston, MA, USA
ASSOCIATION BETWEEN NEWER ANTIRETROVIRALS AND INCREASE IN BODY MASS INDEX IN RESPOND (ABSTRACT
507)
Loveleen Bansi-Matharu
University College London, London, United Kingdom
OBESITY IS HIGHLY PREVALENT IN PEOPLE OF AFRICAN ANCESTRY LIVING WITH HIV IN THE UK (ABSTRACT
508)
Rachel K.Y. Hung
King's College London, London, United Kingdom
WEIGHT GAIN AMONG PARTICIPANTS STARTING DOLUTEGRAVIR-BASED HIV REGIMEN IN KENYA (ABSTRACT
509)
Kassem Bourgi
Indiana University School of Medicine, Indianapolis, IN, USA
WEIGHT GAIN POST-ART IN HIV+ LATINOS/AS DIFFERS IN THE US, CANADA, AND LATIN AMERICA (ABSTRACT
510)
Lara Coelho
Fiocruz, Rio de Janeiro, Brazil
CHARACTERISTICS OF HIV+ AND HIV- PATIENTS UNDERGOING BARIATRIC SURGERY: OBEVIH STUDY (ABSTRACT
511)
Valérie Pourcher
Pitié-Salpêtrière University Hospital, Paris, -- None --, France
METABOLOMIC SIGNATURES DIFFERENTIATE WOMEN WHO GAIN WEIGHT WITH INTEGRASE INHIBITORS (ABSTRACT
512)
Cecile D Lahiri
Emory University, Atlanta, GA, USA
URINE MITOCHONDRIAL DNA, WEIGHT LOSS, AND BODY COMPOSITION IN OLDER ADULTS WITH HIV (ABSTRACT
513)
Carrie Johnston
Weill Cornell, New York, NY, USA
IN VITRO MODEL TO ASSESS ANTIRETROVIRAL THERAPY ON ADIPOCYTE BIOLOGY (ABSTRACT
514)
R. Taylor Pickering
Boston Medical Center, Boston, MA, USA
INTEGRASE INHIBITORS TARGET MITOCHONDRIA IN BROWN ADIPOCYTES DISRUPTING THERMOGENESIS (ABSTRACT
515)
Sangwon F Kim
Johns Hopkins University School of Medicine, Baltimore, MD, USA
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
13 of
13
|